MeSH tree: C12.050.351.937
Some people inherit genetic changes that put them at higher risk of developing certain cancers or heart disease. A simple genetic test can identify those risks early, creating opportunities to prevent disease or detect it ...
14 hours ago
0
2
Two in five women with ovarian cancer are diagnosed only after an emergency hospital admission, when they are three times less likely to have early-stage and potentially curable disease, finds a data analysis published in ...
Jul 7, 2026
0
4
For patients with clear-cell renal cell carcinoma, pembrolizumab-belzutifan yields significantly higher disease-free survival, according to a study published in the July 2 issue of the New England Journal of Medicine.
Jul 6, 2026
0
3
New research from Liverpool School of Tropical Medicine (LSTM) has highlighted the need to test millions of women and girls for female genital schistosomiasis (FGS), a neglected disease that can increase the risk of chronic ...
Jul 2, 2026
0
8
A common genetic mutation that helps some kidney cancers survive may also expose an unexpected weakness, one that MUSC Hollings Cancer Center researchers hope to transform into a new treatment strategy. In a study published ...
Jun 29, 2026
0
3
Air pollution is globally recognized as a silent killer, with its detrimental effects on the respiratory and cardiovascular systems well documented. However, a pioneering study from Taiwan sheds light on a less visible but ...
Jun 29, 2026
0
2
Northwestern Medicine scientists have, for the first time, described the underlying mechanisms that regulate how cells rapidly change gene expression in response to hypoxia, a key feature of many treatment-resistant tumors, ...
Jun 27, 2026
0
8
Researchers at Weill Cornell Medicine, Cedars-Sinai Medical Center and Roswell Park Comprehensive Cancer Center have developed genetically engineered CAR T cells that specifically target and kill bladder cancer cells. The ...
Jun 26, 2026
0
6
A target trial emulation study found that among women with cervical intraepithelial neoplasia (CIN) grade 2 (CIN 2), a moderate form of precancerous cervical dysplasia, excision within six months did not lower three-year ...
Jun 22, 2026
0
2
The U.S. Food and Drug Administration has approved Merck's Welireg (belzutifan) in combination with pembrolizumab or pembrolizumab and berahyaluronidase alfa-pmph (Keytruda Qlex) for the adjuvant treatment of renal cell carcinoma ...
Jun 19, 2026
0
8
